Literature DB >> 30759489

Congenital Hypopituitarism: Various Genes, Various Phenotypes.

Maria Xatzipsalti1,2, Antonis Voutetakis1, Lela Stamoyannou2, George P Chrousos1, Christina Kanaka-Gantenbein1.   

Abstract

The ontogenesis and development of the pituitary gland is a highly complex process that depends on a cascade of transcription factors and signaling molecules. Spontaneous mutations and transgenic murine models have demonstrated a role for many of these factors, including HESX1, PROP1, PIT1, LHX3, LHX4, SOX2, SOX3, OTX2, PAX6, FGFR1, SHH, GLI2, and FGF8 in the etiology of congenital hypopituitarism. Genetic mutations in any of these factors can lead to congenital hypopituitarism, which is characterized by the deficiency in one or more pituitary hormones. The phenotype can be highly variable, consisting of isolated hypopituitarism or more complex disorders. The same phenotype can be attributed to different gene mutations; while a given gene mutation can induce different phenotypes. This review highlights the genetic variations that lead to congenital hypopituitarism and their associated defects. The overall incidence of mutations in known transcription factors in patients with hypopituitarism is low; therefore many gene mutations or even gene- epigenetic interactions have to be unraveled in the future to explain the vast majority of still unclear cases of congenital hypopituitarism. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 30759489     DOI: 10.1055/a-0822-3637

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

1.  LONG TERM FOLLOW-UP OF ONE OF THE FIRST PATIENTS TO RECEIVE HUMAN GROWTH HORMONE THERAPY.

Authors:  Cassandra Hawco; Robyn L Houlden
Journal:  AACE Clin Case Rep       Date:  2020-06-23

Review 2.  Management of Hypopituitarism.

Authors:  Krystallenia I Alexandraki; AshleyB Grossman
Journal:  J Clin Med       Date:  2019-12-05       Impact factor: 4.241

Review 3.  Congenital Hypopituitarism During the Neonatal Period: Epidemiology, Pathogenesis, Therapeutic Options, and Outcome.

Authors:  Laura Bosch I Ara; Harshini Katugampola; Mehul T Dattani
Journal:  Front Pediatr       Date:  2021-02-02       Impact factor: 3.418

4.  Presentation and diagnosis of childhood-onset combined pituitary hormone deficiency: A single center experience from over 30 years.

Authors:  Johanna Hietamäki; Juho Kärkinen; Anna-Pauliina Iivonen; Kirsi Vaaralahti; Annika Tarkkanen; Henrikki Almusa; Hanna Huopio; Matti Hero; Päivi J Miettinen; Taneli Raivio
Journal:  EClinicalMedicine       Date:  2022-07-18

Review 5.  Delayed Diagnosis of Congenital Combined Pituitary Hormone Deficiency including Severe Growth Hormone Deficiency in Children with Persistent Neonatal Hypoglycemia-Case Reports and Review.

Authors:  Joanna Smyczyńska; Natalia Pawelak; Maciej Hilczer; Andrzej Lewiński
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

Review 6.  The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye.

Authors:  Dulce Lima Cunha; Gavin Arno; Marta Corton; Mariya Moosajee
Journal:  Genes (Basel)       Date:  2019-12-17       Impact factor: 4.096

Review 7.  The Genetic Backdrop of Hypogonadotropic Hypogonadism.

Authors:  Anna Szeliga; Michal Kunicki; Marzena Maciejewska-Jeske; Natalia Rzewuska; Anna Kostrzak; Blazej Meczekalski; Gregory Bala; Roman Smolarczyk; Eli Y Adashi
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.